UK DanceBlue Distinguished Professorship in Pediatric Hematology/Oncology

Lexington, Kentucky
Academic appointment and salary will be commensurate with prior experience.
May 22, 2018
Jun 21, 2018
Full Time


Department of Pediatrics, Division of Pediatric Hematology/Oncology

UK DanceBlue Distinguished Professorship in Pediatric Hematology/Oncology

Kentucky Children’s Hospital and the University of Kentucky are seeking to recruit a clinician scientist or physician scientist with an outstanding record of clinical and research endeavors related to pediatric hematology/oncology. This endowed position would support pediatric oncology research endeavors in the form of protected time, space and other resources.   The ideal candidate would join a vibrant and collaborative division of pediatric hematologists/oncologists and would:

  1. be recruited at the Associate Professor or Professor level, with tenure
  2. have an outstanding research history and ongoing research interests clearly linked to pediatric hematology/oncology
  3. have at least 50% effort available for research
  4. demonstrate effective clinical service and teaching in pediatric hematology/oncology
  5. hold an MD or MD/PhD or equivalent with a sustained record of scholarly activity

Division of Pediatric Hematology/Oncology ( The Division of Pediatric Hematology/Oncology is comprised of six faculty, three advanced care providers, three social workers, one dedicated child life specialist, a school intervention specialist, three PharmD’s, and a dietician.  We are an active clinical research program, ranking at the 75th percentile for COG therapeutic trial enrollments, with 3 members of the research/regulatory team.  We are members of the National Pediatric Cancer Foundation, the Advanced Clinical Trials Network (with Cincinnati Children’s Medical Center), and the Neuroblastoma Medulloblastoma Translational Research Consortium. We currently care for oncology patients up to 30 years of age who have a diagnosis that is commonly managed by pediatric oncologists. In the last three calendar years we have had between 73-81 new oncology patients per year, up from 45 in 2012. For FY 2017, we had 3600 clinic visits (up 18% from 2 years before). Our new outpatient clinic opened in January 2017, increasing clinic space from 2,200 to 4,000 sq. ft., including more exam rooms (from 4 to 6) and infusion beds (from 4 to 10). Division office space is immediately behind the clinic, facilitating efficiency and encouraging frequent interactions.  The clinic and faculty office spaces are conveniently located down the hall from the inpatient area, and two floors above Children’s Sedation and Procedure Unit where intrathecal infusions, LPs and bone marrows are completed. We use an electronic medical record (SCM/Allscripts) with electronic chemotherapy ordering. Faculty include:

  • John D’Orazio, MD, PhD – currently interim division chief; on faculty since 2004; physician/scientist with clinical interests in hematology and research interest in melanoma and DNA repair
  • Vlad Radulescu, MD – currently interim clinical operations director; on faculty since 2006; director of the Hemophilia Treatment Center, with clinical interests also in thrombophilia and hemoglobinopathies
  • Sherry Bayliff, MD, MPH – on faculty since 2001; directs the Vascular Anomalies Clinic
  • Tom Badgett, MD, PhD – on faculty since 2012; director of the Leukemia Program
  • Caryn Sorge, MD – joined faculty July 2016, clinical interests in lymphoma and adolescent/young adult patients; directs the Childhood Survivorship Clinic
  • Jack Geil, MD – on faculty since 1981; clinical interests include hematology and brain tumors; now part-time and works clinics only

Existing Programs within Pediatric Hematology/Oncology include a Hemophilia Treatment Center, Multidisciplinary Vascular Anomalies Clinic, Childhood Cancer Survivorship Clinic, Hemoglobinopathy Clinic, Dysfunctional Uterine Bleeding Clinic, and the Multidisciplinary Neuro-Oncology Clinic.  Planned Clinics in Development include an Adolescent and Young Adult Program and Inherited cancer syndromes. 

DanceBlue Philanthropic Organization.  The UK DanceBlue Distinguished Professorship in Pediatric Hematology/Oncology is made possible by philanthropic support of DanceBlue (, an annual student-run 24-hour dance marathon in existence at the University of Kentucky since 2006 that raises support for pediatric cancer. With fundraising numbers increasing each year, in 2018 DanceBlue raised 1.8 million dollars. Funding from DanceBlue has been used for laboratory and clinical research projects, staff support (e.g., Child Life and school intervention specialist), and patient support services. DanceBlue provided $1.2 million in funding for the renovation of our new clinic, which opened in 2017, and donated a $2 million endowment as of spring 2018 to establish the UK DanceBlue Distinguished Professorship in Pediatric Hematology/Oncology.

Department of Pediatrics (  The Division of Pediatric Hematology/Oncology is a major Division within the Department of Pediatrics.  The Department of Pediatrics consists of over ninety (90) faculty members and is composed of abuse, child advocacy, child psychiatry, community pediatrics, critical care, endocrinology, gastroenterology, genetics/metabolism, general pediatrics, hematology/oncology, hospitalist, infectious disease, neonatology, nephrology, neurology, pediatric surgery, pulmonary, radiology, research, rheumatology, and school health. The Department has an outstanding training program in General Pediatrics and three combined training programs: 1) Internal Medicine and Pediatrics, 2) Adult Psychiatry and Child Psychiatry, and 3) Child Neurology. UK Pediatrics also offers unique programs directed at child advocacy and international health.

Kentucky Children’s Hospital ( The Kentucky Children’s Hospital (KCH), a hospital-within-a hospital, serves as a subspecialty regional referral and pediatric care center for Central and Eastern Kentucky. A new KCH entrance and 36,000 sq. ft. NICU opened in April 2018. The new entrance symbolizes the first time that Kentucky Children’s Hospital will truly have a front door. KCH is a 133-bed facility with 43 acute care (non-ICU) beds, 12-bed PICU, 70-bed NICU, 12-bed step down unit, and 8-bed outpatient area open 24 hours daily for medication infusions or observations. Following a “Hospital within a hospital” model with dedicated pediatric radiology, surgery, transport, sedation team and phlebotomy services, KCH offers full service in-house multidisciplinary support for pediatrics and young adult patients up to age 29 years.

•   Over 100 pediatric faculty, including over 70 subspecialists

•   PICU team with 8 intensivists performing 25 ECMO cases per year

•   Four pediatric surgeons actively engaged with pediatric oncology program

•   Residency programs in pediatrics, pediatric neurology, medicine-pediatrics, and pediatric psychiatry (triple board)

•   Fellowship training program in neonatology

University of Kentucky ( The University of Kentucky (UK) is a leading land-grant and public research university located in the beautiful Bluegrass region of central Kentucky. Counted among the highest level of Carnegie Research institutions, the University is in the midst of aggressive efforts to become one of the nation’s premier public research universities with expectations that the College of Medicine will grow significantly in research stature and NIH ranking.

UK College of Medicine ( Founded in 1960, the UK College of Medicine (UKCOM) produces highly qualified, caring physicians and the next generation of biomedical scientists to serve the people of Kentucky and the nation. Grants and contracts in UKCOM reached over $100 million last year, including nearly $80 million in National Institutes of Health (NIH) funding. The College is one of six health-related colleges at the University (Dentistry, Health Sciences, Medicine, Nursing, Pharmacy, and Public Health) and is located on UK’s main campus in Lexington, KY.

Markey Cancer Center (  The UKCOM is affiliated with the Lucille P. Markey Cancer Center (MCC).  The MCC is one of only 69 NCI-designated cancer centers in the country and the only NCI-designated cancer center in Kentucky. Located immediately adjacent to the Children’s Hospital and outpatient clinic,  the MCC is a matrix cancer center with 120 research members organized into four research programs: 1) cancer cell biology and signaling (CS), 2) cancer prevention and control (CP), 3) drug discovery, delivery, and therapeutics (DT), and 4) genomic instability, epigenetics and metabolism (GEM).  Dr. John D’Orazio, Interim Chief of the Division of Pediatric Hematology/Oncology, co-leads the genomic instability, epigenetics and metabolism (GEM) basic science research program.   The MCC holds regular biweekly tumor boards for neuro-oncology and musculoskeletal oncology carried out jointly with adults and pediatrics.  One pediatric hematology/oncology member (Dr. John D’Orazio) is actively engaged in R01-supported basic science research within the MCC, and another (Dr. Tom Badgett) collaborates with Markey basic scientists on two translational pediatric leukemia projects.  The MCC holds bi-weekly molecular tumor board multidisciplinary conferences where pediatric and adult oncology cases with potential targetable mutations are discussed.  Cancer research at UK has grown steadily over the last 10 years, now accruing roughly $50 million annually from NIH. 

Lexington KY and the Bluegrass (  Lexington, Kentucky, has a population estimated at more than 295,000 with a larger metro area of more than 550,000, and is often ranked as one of the best places to live in the country.  It is located approximately 70 miles from Cincinnati and Louisville, thus creating a "Golden Triangle."


How to Apply

Candidates should apply by email to John D'Orazio, MD, PhD, Interim Chief, Division of Pediatric Hematology/Oncology and Professor of Pediatrics, University of Kentucky College of Medicine, Combs Cancer Research Bldg. Rm. 204, 800 Rose Street, Lexington, KY 40536-0096, Email:  Applications should include a curriculum vita, description of research interests and goals for developing a strong research program. Applicants should also provide the names and addresses of at least three professional references. Applications will be reviewed as received and invitations to interview will be extended to competitive candidates.

The University of Kentucky is an Equal Opportunity University that values diversity and inclusion. Individuals with disabilities, minorities, veterans, women, and members of other underrepresented groups are encouraged to apply.